Skip to content

H.R. 1463 · 119th Congress (2025–2027)

To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.

This bill prohibits the use of federal funds to implement, administer, or enforce the final rule issued by the Food and Drug Administration (FDA) titled Medical Devices; Laboratory Developed Tests and published on May 6, 2024, or any substantially similar rule.

The rule specifies that laboratory developed tests (medical screening tests developed by laboratories rather than medical device manufacturers) are medical devices subject to FDA regulation with limited exceptions. Prior to the rule, the FDA had exercised discretion as to whether to apply regulations for medical devices to laboratory developed tests.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 1463’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Brad Finstad (R-MN-1)
Cosponsors
7 cosponsors

1 original · 6 later

7 R

  1. Rep. Dan Crenshaw (R-TX-2)· Original · Feb 21, 2025
  2. Rep. Mariannette Miller-Meeks (R-IA-1)· Later · Feb 24, 2025
  3. Rep. Randy K. Weber, Sr. (R-TX-14)· Later · Feb 27, 2025
  4. Rep. August Pfluger (R-TX-11)· Later · Mar 4, 2025
  5. Rep. Neal P. Dunn (R-FL-2)· Later · Mar 21, 2025
  6. Rep. Andy Barr (R-KY-6)· Later · Apr 1, 2025
  7. Rep. Craig A. Goldman (R-TX-12)· Later · Aug 8, 2025
Policy area
Health
Subjects
  • Administrative law and regulatory procedures
  • Drug safety, medical device, and laboratory regulation
  • Food and Drug Administration (FDA)
  • Health programs administration and funding
  • Medical tests and diagnostic methods

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Feb 21, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (1)
  1. To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.

    Display title, Official title · Introduced in House